Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
EPS Diluted Over TimeContracting
Percentile Rank85
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-5.84
↑ 99% vs avg
Percentile
P85
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-837.60
Historical baseline
PeriodValueYoY Change
TTM-5.84-79.1%
2024-3.26+97.1%
2023-113.58+89.3%
2022-1062.65+54.4%
2021-2330.66+7.7%
2020-2523.77-207.9%
2019-819.74+75.3%
2018-3317.28-282.0%
20171822.74+8411.6%
2016-21.93-